AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 194 filers reported holding AXSOME THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.52 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $691,911 | -89.9% | 9,900 | -89.6% | 0.00% | -91.7% |
| Q2 2023 | $6,868,379 | +340.8% | 95,580 | +373.2% | 0.02% | -14.3% |
| Q4 2022 | $1,558,026 | +535.9% | 20,200 | +267.3% | 0.03% | +460.0% |
| Q3 2022 | $245,000 | -28.6% | 5,500 | -33.7% | 0.01% | -44.4% |
| Q1 2022 | $343,000 | -98.1% | 8,295 | -95.1% | 0.01% | -99.2% |
| Q4 2019 | $17,599,000 | +28285.5% | 170,268 | +854.5% | 1.14% | +3837.9% |
| Q3 2018 | $62,000 | – | 17,838 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,132,645 | $37,332,000 | 32.86% |
| MORGAN JESS S & CO INC | 113,430 | $3,739,000 | 2.47% |
| Fairmount Funds Management LLC | 187,598 | $6,183,000 | 2.25% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 1,423,653 | $46,924,000 | 1.43% |
| WMS Partners, LLC | 250,000 | $8,240,000 | 1.21% |
| Beck Bode, LLC | 102,127 | $3,366,000 | 0.94% |
| RTW INVESTMENTS, LP | 1,616,497 | $53,280,000 | 0.80% |
| MPM BioImpact LLC | 110,155 | $3,631,000 | 0.56% |
| Endurant Capital Management LP | 52,048 | $1,716,000 | 0.39% |
| Bellevue Group AG | 752,945 | $24,817,000 | 0.25% |